Teruki Yanagi

Harlequin ichthyosis model mouse reveals alveolar collapse and severe fetal skin barrier defects

Harlequin ichthyosis (HI), which is the most severe genodermatosis, is caused by loss-of-function mutations in ABCA12, a member of the ATP-binding cassette transporter family. To investigate the pathomechanism of HI and the function of the ABCA12 protein, we generated ABCA12-deficient mice (Abca12(-/-)) by targeting Abca12. Abca12(-/-) mice closely reproduce the human HI phenotype, showing marked hyperkeratosis with eclabium and skin fissure. Lamellar granule abnormalities and defective ceramide distribution were remarkable in the epidermis. Skin permeability assay of Abca12(-/-) fetuses revealed severe skin barrier dysfunction after the initiation of keratinization. Surprisingly, the Abca12(-/-) mice also demonstrated lung alveolar collapse immediately after birth. Lamellar bodies in alveolar type II cells of the Abca12(-/-) mice lacked normal lamellar structures. The level of surfactant protein B, an essential component of alveolar surfactant, was reduced in the Abca12(-/-) mice. Fetal therapeutic trials with systemic administration of retinoid or dexamethasone, which are effective for HI and respiratory distress, respectively, to the pregnant mother mice neither improved the skin phenotype nor extended the survival period. Our HI model mice reproduce the human HI skin phenotype soon after the initiation of fetal skin keratinization and provide evidence that ABCA12 plays pivotal roles in lung and skin barrier functions.

An annexin A1–FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions

Annexin A1 secreted from drug-stimulated monocytes contributes to keratinocyte necroptosis in serious drug-related adverse events in skin. Subduing a Severe Skin Side Effect Certain pain relievers and antiepileptic drugs can cause a very rare, but sometimes fatal, side effect in which skin painfully blisters and peels, caused by the patients’ immune response to the drug. Saito et al. now find that, in susceptible patients, the drug causes secretion of the protein annexin A1 from immune cells, with deadly effect on skin cells. Annexin acts on these cells to cause necroptosis, a programmed form of cell death. The authors confirmed their results in mice, showing that an inhibitor of necroptosis blocked skin blistering. With these findings, Saito et al. lay the groundwork for a countermeasure to this dangerous side effect of otherwise extremely beneficial drugs. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening, cutaneous adverse drug reactions that are accompanied by keratinocyte cell death. Dead keratinocytes from SJS/TEN lesions exhibited necrosis, by morphological criteria. Supernatant from peripheral blood mononuclear cells (PBMCs) that had been exposed to the causative drug from patients with SJS/TEN induced the death of SJS/TEN keratinocytes, whereas supernatant from PBMCs of patients with ordinary drug skin reactions (ODSRs) exposed to the same drug did not. Keratinocytes from ODSR patients or from healthy controls were unaffected by supernatant from SJS/TEN or ODSR PBMCs. Mass spectrometric analysis identified annexin A1 as a key mediator of keratinocyte death; depletion of annexin A1 by a specific antibody diminished supernatant cytotoxicity. The necroptosis-mediating complex of RIP1 and RIP3 was indispensable for SJS/TEN supernatant–induced keratinocyte death, and SJS/TEN keratinocytes expressed abundant formyl peptide receptor 1 (FPR1), the receptor for annexin A1, whereas control keratinocytes did not. Inhibition of necroptosis completely prevented SJS/TEN-like responses in a mouse model of SJS/TEN. Our results demonstrate that a necroptosis pathway, likely mediated by annexin 1 acting through the FPR1 receptor, contributes to SJS/TEN.

Radiotherapy for extramammary Paget's disease: histopathological findings after radiotherapy

Summary Several reports have suggested the efficacy of radiotherapy for treating extramammary Pagets disease (EMPD); however, these reports comprised only clinical observations, without in‐depth histopathological observations. We report our experience of genital EMPD treated by radiotherapy in two elderly women, and the marked efficacy of radiotherapy, confirmed both by clinical observation and by detailed histopathological investigations. Our cases agree with the notion that radiotherapy is useful as an alternative therapy for EMPD, and should be considered particularly in elderly patients who may not tolerate surgery well.

CGI-58 Is an α/β-Hydrolase within Lipid Transporting Lamellar Granules of Differentiated Keratinocytes

CGI-58 is the causative molecule underlying Dorfman-Chanarin syndrome, a neutral lipid storage disease exhibiting apparent clinical features of ichthyosis. CGI-58, associated with triacylglycerol hydrolysis, has an alpha/beta-hydrolase fold and is also known as the alpha/beta-hydrolase domain-containing protein 5. The purpose of this study was to elucidate the function of CGI-58 and the pathogenic mechanisms of ichthyosis in Dorfman-Chanarin syndrome. Using an anti-CGI-58 antibody, we found CGI-58 to be expressed in the upper epidermis, predominantly in the granular layer cells, as well as in neurons and hepatocytes. Immunoelectron microscopy revealed that CGI-58 was also localized to the lamellar granules (LGs), which are lipid transport and secretion granules found in keratinocytes. CGI-58 expression was markedly reduced in the epidermis of patients with harlequin ichthyosis, demonstrating defective LG formation. In cultured keratinocytes, CGI-58 expression was mildly up-regulated under high Ca(2+) conditions and markedly up-regulated in three-dimensional, organotypic cultures. In the developing human epidermis, CGI-58 immunostaining was observed at an estimated gestational age of 49 days, and CGI-58 mRNA expression was up-regulated concomitantly with both epidermal stratification and keratinocyte differentiation. CGI-58 knockdown reduced expression of keratinocyte differentiation/keratinization markers in cultured human keratinocytes. Our results indicate that CGI-58 is expressed and packaged into LGs during keratinization and likely plays crucial role(s) in keratinocyte differentiation and LG lipid metabolism, contributing to skin lipid barrier formation.

ATG4B (Autophagin-1) phosphorylation modulates autophagy.

Background: ATG4B mediates the cleavage of pro-LC3 and removes lipid conjugates from LC3 during autophagy. Results: We determined that defects in phosphorylation of ATG4B reduced its hydrolyase activity and impaired autophagic flux. Conclusion: Phosphorylation of ATG4B plays an important role in modulating its hydrolyase activity. Significance: This is the first report showing a role for phosphorylation of an ATG4-family protease in control of autophagy. Autophagy is a catabolic cellular mechanism for entrapping cellular macromolecules and organelles in intracellular vesicles and degrading their contents by fusion with lysosomes. Important roles for autophagy have been elucidated for cell survival during nutrient insufficiency, eradication of intracellular pathogens, and counteracting aging through clearance of senescent proteins and mitochondria. Autophagic vesicles become decorated with LC3, a protein that mediates their fusion with lysosomes. LC3 is a substrate of the cysteine protease ATG4B (Autophagin-1), where cleavage generates a C-terminal glycine required for LC3 conjugation to lipids in autophagosomes. ATG4B both cleaves pro-LC3 and also hydrolyzes lipids from cleaved LC3. We show here that phosphorylation of ATG4B at Ser-383 and Ser-392 increases its hydrolyase activity as measured using LC3 as a substrate. Reconstituting atg4b−/− cells with phosphorylation-deficient ATG4B showed a role of ATG4B phosphorylation in LC3 delipidation and autophagic flux, thus demonstrating that the cellular activity of ATG4B is modulated by phosphorylation. Proteolytic conversion of pro-LC3 to LC3-I was not significantly impacted by ATG4B phosphorylation in cells. Phosphorylation-deficient ATG4B also showed reduced interactions with the lipid-conjugated LC3 but not unconjugated LC3. Taken together, these findings demonstrate a role for Ser-383 and Ser-392 phosphorylation of ATG4B in control of autophagy.

ABCA12 dysfunction causes a disorder in glucosylceramide accumulation during keratinocyte differentiation.

Fig. 1. KT1 and HIKT keratinocyte cell lines. KT1 and HIKT keratinocyte cell lines were gen of CCRIP-pMFGtsT (distributed from RIKEN cell bank, Tsukuba, Japan). After 15 passag levels of T-antigen as examined by Western blotting using anti-SV40 LT (BD bioscienc mutation from A to G in HIKT cells. RT-PCR analysis of mRNA fragments around the ex *Corresponding author at: Department of Physiology, University of Tartu, 19 Ravila Street, 50411 Tartu, Estonia. Tel.: +372 7 374 335; fax: +372 7 374 332 E-mail address: Sulev.Koks@ut.ee (S. Kõks)

Follicular mucinosis associated with imatinib (STI571)

1 Niwa Y, Terashima T, Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 2003; 149: 960–7. 2 Jiang H, Yamamoto S, Nishikawa K, Kato R. Anti-tumor-promoting action of FK-506, a potent immunosuppressive agent. Carcinogenesis 1993; 14: 67–71. 3 Protopic label information. http://www.protopic.com/img/ protopic_pi.pdf 4 Gschwendt M, Kittstein W, Marks F. Cyclosporin A inhibits phorbol ester-induced cellular proliferation and tumor promotion as well as phosphorylation of a 100-kd protein in mouse epidermis. Carcinogenesis 1987; 8: 203–7. 5 Yokota K, Gill TJ 3rd, Shinozuka H. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis. Cancer Res 1989; 49: 4586– 90. 6 Gschwendt M, Kittstein W, Marks F. The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPAinduced biological effects in mouse skin and of Ca2+ ⁄ calmodulin dependent EF-2 phosphorylation in vitro. Biochem Biophys Res Commun 1988; 150: 545–51. 7 Elder JT, Gupta AK, Fisher GJ, Voorhees JJ. Cyclosporine inhibits ornithine decarboxylase gene expression and acute inflammation in response to phorbol ester treatment of hairless mouse skin. Transplant Proc 1988; 20 (Suppl. 4): 95–104.

PCTAIRE1 Phosphorylates p27 and Regulates Mitosis in Cancer Cells

PCTAIRE1 is distant relative of the cyclin-dependent kinase family that has been implicated in spermatogenesis and neuronal development, but it has not been studied in cancer. Here, we report that PCTAIRE1 is expressed in prostate, breast, and cervical cancer cells, where its RNAi-mediated silencing causes growth inhibition with aberrant mitosis due to defects in centrosome dynamics. PCTAIRE1 was not similarly involved in proliferation of nontransformed cells, including diploid human IMR-90 fibroblasts. Through yeast two-hybrid screening, we identified tumor suppressor p27 as a PCTAIRE1 interactor. In vitro kinase assays showed PCTAIRE1 phosphorylates p27 at Ser10. PCTAIRE1 silencing modulated Ser10 phosphorylation on p27 and led to its accumulation in cancer cells but not in nontransformed cells. In a mouse xenograft model of PPC1 prostate cancer, conditional silencing of PCTAIRE1 restored p27 protein expression and suppressed tumor growth. Mechanistic studies in HeLa cells showed that PCTAIRE1 phosphorylates p27 during the S and M phases of the cell cycle. Notably, p27 silencing was sufficient to rescue cells from mitotic arrest caused by PCTAIRE1 silencing. Clinically, PCTAIRE1 was highly expressed in primary breast and prostate tumors compared with adjacent normal epithelial tissues. Together our findings reveal an unexpected role for PCTAIRE1 in regulating p27 stability, mitosis, and tumor growth, suggesting PCTAIRE1 as a candidate cancer therapeutic target.

Naevus sebaceus on the female breast accompanied with a tubular apocrine adenoma and a syringocystadenoma papilliferum

1 Bolduc C, Shapiro J. Hair care products: waving, straightening, conditioning, and coloring. Clin Dermatol 2001; 19:431–6. 2 Kaur BJ, Singh H, Lin-Greenberg A. Irritant contact dermatitis complicated by deep-seated staphylococcal infection caused by a hair relaxer. J Natl Med Assoc 2002; 94:121–3. 3 Swee W, Klontz KC, Lambert LA. A nationwide outbreak of alopecia associated with the use of a hair-relaxing formulation. Arch Dermatol 2000; 136:1104–8. 4 Nicholson AG, Harland CC, Bull RH et al. Chemically induced cosmetic alopecia. Br J Dermatol 1993; 128:537–41. 5 Nnoruka EN. Hair loss: is there a relationship with hair care practices in Nigeria? Int J Dermatol 2005; 44 (Suppl. 1):13–17. 6 Wilborn W. Disorders of hair growth in African Americans. In: Disorders of Hair Growth, Diagnosis and Treatment (Olsen E, ed.). New York: McGraw-Hill, 1994; 401. 7 Miller JJ. Relaxer-induced alopecia. Am J Contact Dermat 2001; 12:238–9. 8 Sperling LC, Sau P. The follicular degeneration syndrome in black patients. ’Hot comb alopecia’ revisited and revised. Arch Dermatol 1992; 128:68–74. 9 Sperling LC. Scarring alopecia and the dermatopathologist. J Cutan Pathol 2001; 28:333–42. 10 Keita S, Faye O, Kane BD et al. Hair care and hair styles in women in Bamako, Mali. Int J Dermatol 2005; 44 (Suppl. 1):26–9.

PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines

While PCTAIRE1/PCTK1/Cdk16 is overexpressed in malignant cells and is crucial in tumorigenesis, its function in apoptosis remains unclear. Here we investigated the role of PCTAIRE1 in apoptosis, especially in the extrinsic cell death pathway. Gene-knockdown of PCTAIRE1 sensitized prostate cancer PPC1 and Du145 cells, and breast cancer MDA-MB-468 cells to TNF-family cytokines, including TNF-related apoptosis-inducing ligand (TRAIL). Meanwhile, PCTAIRE1-knockdown did not sensitize non-malignant cells, including diploid fibroblasts IMR-90 and the immortalized prostate epithelial cell line 267B1. PCTAIRE1-knockdown did not up-regulate death receptor expression on the cell surface or affect caspase-8, FADD and FLIP expression levels. PCTAIRE1-knockdown did promote caspase-8 cleavage and RIPK1 degradation, while RIPK1 mRNA knockdown sensitized PPC1 cells to TNF-family cytokines. Furthermore, the kinase inhibitor SNS-032, which inhibits PCTAIRE1 kinase activity, sensitized PPC1 cells to TRAIL-induced apoptosis. Together these results suggest that PCTAIRE1 contributes to the resistance of cancer cell lines to apoptosis induced by TNF-family cytokines, which implies that PCTAIRE1 inhibitors could have synergistic effects with TNF-family cytokines for cytodestruction of cancer cells.